- Investing Ideas
- Tunisian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Tunisian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
1
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
1 companies